View on market: Volatility persists, eagerly searching for growth:
Global markets witnessed heightened volatility as escalating tensions in the Middle East triggered a sharp shift away from riskier assets. Equity markets across regions declined as investors reacted to military action involving the United States and Israel against Iran. The conflict pushed crude oil prices higher and strengthened the US dollar, reflecting a move toward safer assets. Asian markets followed the weak global trend and closed lower, while futures linked to major US and European indices also indicated continued pressure. In the United States, stock futures dropped significantly at the start of the week as fears grew that the conflict could widen further across the region. The renewed geopolitical stress added to existing market nervousness related to uncertainty around artificial intelligence and concerns about private credit exposure within the technology sector. Indian equity markets also ended the month on a weak note, extending recent losses. Financial, energy and automobile stocks dragged the indices lower, while information technology shares showed some resilience after earlier declines.
Economic Calendar:
- USD: S&P Global and ISM Manufacturing PMI Data on 02nd March 2026.
- IND: S&P Global Manufacturing PMI Data on 02nd March 2026.
- USD: S&P Global Services PMI and Crude Oil Inventory Data on 04th March 2026.
- IND: Industrial Production Data on 02nd March 2026.
Brokerage Radar:
CITI ON BHARTI AIRTEL:
Target ₹2,380 Recommendation Buy, Chairman’s clear strategic vision amid market concerns reinforces a compelling long-term opportunity, Uncertainty around the timing of the next tariff hike may limit near-term catalysts, Believe the stock’s recent under-performance presents an enhanced buying opportunity, Also see the most immediate positive read-through for Indus Towers.
JPMORGAN ON DIXON TECH:
Target ₹13700 Recommendation Overweight, Mobile PLI 2.0 would be a bit different than the existing scheme, Believe the Street has been assuming that the PLI scheme would not be extended, Dixon’s mobile business would see a 50bps margin reduction from FY27, If the scheme were to be extended, Dixon could continue to enjoy a 50bps margin benefit, This could lead to 12-16% EPS upgrades over FY27-28.
GOLDMAN SACHS ON ICICI LOMBARD:
Target ₹1,925 Recommendation Neutral, Industry growth inflected in Q3, Motor growth outpaced industry in Q3, Company motor combined ratio materially better than industry, Health: strategic investment phase, near-term drag acceptable.
JEFFERIES INDIA STRATEGY:
Middle East Conflict – Impact likely to be short-term, India’s economic links with the Middle East are strong, with the region taking 17% of India’s exports and providing 55% of its crude oil and 38% of worker remittances, A prolonged conflict, alongside a large jump in energy prices, would be a major macro negative, However, recent regional conflicts have been temporary, and a dip could be a buying opportunity.
International Markets:
U.S & Europe:
| Particulars | 27th Feb | Chg. | Chg.(%) |
| Nasdaq | 22,668.21 | -210.17 | -0.92 |
| Dow | 48,977.92 | -521.28 | -1.05 |
| FTSE | 10,910.55 | 63.85 | 0.59 |
| CAC | 8,580.75 | -40.18 | -0.47 |
| DAX | 25,284.26 | -4.76 | -0.02 |
| Dow Fut.* | 48,691.28 | -286.64 | -0.59 |
*As per 02ndMarch.
Asian markets:
| Particulars | 02nd Mar | Chg. | Chg.(%) |
| GIFT Nifty | 25,182.00 | -153.50 | -0.61 |
| Nikkei | 58,016.00 | -834.27 | -1.42 |
| Straits Times | 4,901.16 | -93.91 | -1.88 |
| Hang Seng | 26,029.00 | -601.54 | -2.29 |
| Shanghai | 4,155.46 | -7.42 | -0.18 |
Stocks strong on Chart:
| Index | F&O | Cash |
| EICHERMOT | CGPOWER | RALLIS INDIA |
| MAXHEALTH | NBCC | CEAT |
| ICICIBANK | MOTHERSON | BEML |
| BAJAJ-AUTO | PFC | MAX ESTATE |
| BEL | TVSMOTOR | NIPPON AMC |
| SBIN | ASHOKLEY | MINDACORP |
Commodities & Currency:
| Particulars | Current Price | Chg.(%) |
| USD/INR | 91.254 | 0.23 |
| Brent | 76.18 | 5.10 |
| Gold | 161,971 | -0.08 |
| Silver | 274,389 | -0.22 |
FIIs & DIIs:
| Particulars | 27th Feb | 26th Feb |
| FIIs | -7,536.36 | -3,465.99 |
| DIIs | 12,292.81 | 5,031.57 |
News Updates:
| Jio Financial: | Its subsidiary launches the JioFinance app and rolls out ‘Finsider,’ a smart digital marketplace platform. |
| CBI: | The bank enters into a distribution pact with Canara Robeco Asset Management Company to provide its mutual fund products to customers. |
| LIC: | The corporation commences operations at its new IFSC branch located in GIFT City. |
| Aurobindo Pharma: | The US FDA completes an inspection at its subsidiary’s Telangana facility (Eugia Pharma Unit-1) and issues four observations. |
| Anupam Rasayan: | Its arm completes the 100% stake acquisition of Jayhawk Fine Chem for $150 million. |
| Niva Bupa: | It receives a show cause notice from IRDAI regarding business operations but expects no financial impact. |
| Lupin Limited: | It’s subsidiary is set to acquire a full stake in VISUfarma, with the transaction likely to be completed by April. |
| GAIL India: | It plans to set up a wind power project in Maharashtra with an investment of Rs 1,736 crore. |
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
- all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
- No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale. Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
- EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
- EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
-
-
-
-
-
- Compensation
-
-
-
-
-
- EWL or its associates have not received any compensation from the subject company in the past twelve months;
- EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
- EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
- EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
- EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
- In respect of Public Appearances
- EWL or its associates have not received any compensation from the subject company in the past twelve months;
- The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL


